FDA Approves New Once-a-Day HIV Pill Print E-mail
By CHERI CHENG - FDA News Today   
Saturday, 07 November 2015 17:51

The U.S. FDA has approved a new HIV pill that will make taking medications easier for HIV positive patients. The incurable infection, HIV (human immunodeficiency virus) leads to AIDS.



The pill, which is an updated version of an older pill named Stribild, contains four HIV drugs, which include elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Unlike the old version, Genvoya was designed to reduce toxic side effects. Stribild, which also contains four drugs, used a different formulation of tenofovir.


"Genvoya contains a new form of tenofovir that has not been previously approved. This new form of tenofovir provides lower levels of drug in the bloodstream, but higher levels within the cells where HIV-1 replicates," the FDA explained in a statement. "Genvoya appears to be associated with less kidney toxicity and decreases in bone density than previously approved tenofovir-containing regimens based on laboratory measures."






"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!